论文部分内容阅读
目的了解心血管类中成药的应用现状及发展的趋势,为临床上合理用药提供参考。方法采用频度分析,金额排序,每日治疗费用以及序号比分析等方法,对安阳市中医药附属医院2008年至2010年心血管类中成药进行统计学分析。结果本研究显示心血管类药物所占的总金额呈逐年上升的趋势,其中心血管类中成药使用频度与其他类型的心血管类药物相比显著升高;消耗的金额最大的为注射用丹参粉针剂;2009年心血管类药物中DDDs前6位的中成药为注射用丹参粉针剂、血塞通软胶囊、复方丹参滴丸、通心络胶囊、银杏叶片、血塞通注射液。结论本研究显示心血管类中成药的用药基本符合安全、有效、经济的用药原则,临床上心血管病口服制剂为主要的剂型,消耗金额以注射剂为首。
Objective To understand the current status and development trend of cardiovascular traditional Chinese medicines and provide a reference for the rational use of drugs in clinical practice. Methods The frequency of analysis, the amount of the order, the daily cost of treatment and serial number ratio analysis and other methods, Anyang City Hospital of Traditional Chinese Medicine from 2008 to 2010 cardiovascular class of proprietary Chinese medicines for statistical analysis. Results The study showed that the total amount of cardiovascular drugs showed an upward trend year by year, of which the use of cardiovascular drugs in the frequency of use of cardiovascular drugs compared with other types of significant increase; the amount of consumption for injection Danshen injection; cardiovascular drugs in 2009 the first six DDDs proprietary Chinese medicines for the injection of Salvia powder injection, Xuesaitong soft capsules, compound Danshen dripping pills, Tongxinluo capsule, ginkgo leaf, Xuesaitong injection. Conclusion This study shows that the administration of proprietary Chinese medicines for cardiovascular is basically in line with the principle of safe, effective and economical medication. The clinical preparations of oral preparations of cardiovascular diseases are the main dosage forms, with the injection amount being the most important.